Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 2022

View Archived Issues

New blood sugar regulatory hormone discovered

Immunization with MERS-CoV RNA replicons proves to be safe and effective in mice

Researchers find novel PTSD-related biomarkers

Regulation of SWI/SNF complex SMARCA2/4 subunits for treating enhancer-addicted prostate cancer

InflaRx advances oral C5aR inhibitor INF-904 toward clinic

Autobahn Therapeutics discloses thyroid hormone receptor agonists

Century and Bristol Myers Squibb collaborate to develop iPSC-derived allogeneic cell therapies

Sato Pharmaceutical patents new HPGDS inhibitors

Researchers present new F-BODIPY dyes for cancer

AC Immune synthesizes NLRP3 inflammasome inhibitors

Surrozen advances research pipeline targeting Wnt pathway

Betta Pharmaceuticals discloses new HIF-2alpha inhibitors

Pfizer and Codex DNA collaborate to leverage EDS technology for mRNA-based vaccines

Combination of rifampicin and resveratrol shows promise in models of neurodegenerative dementia

Tenaya expands heart disease pipeline with selection of TN-401 as development candidate

Carisma and Moderna collaborate to generate and develop in vivo CAR-M therapeutics

HotSpot and Caris enter strategic partnership to advance HotSpot's portfolio

Acadia and Stroke collaborate on novel RNA-based medicines for neurodevelopmental diseases

Targeting aggregated TDP-43 as new strategy for development of ALS and FTLD therapies

BioNTech and Crescendo Biologics partner to develop immunotherapies for cancer and other diseases

Amarna and Redoxis receive grant to support ALPHAVAC project in neurodegenerative diseases

DiNAQOR and CMRI enter research collaboration on cardiac specific AAV capsids

Mydecine completes model of new serotonin receptor for AI-driven drug discovery program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...